Stock Information
TG Therapeutics Inc (TGTX)
Ticker Symbol: TGTX
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $4,774.25 mil
Piotroski score: 3
PE Ratio: 10.7648
EPS (TTM): 2.777
Revenue (TTM): $3.87 M
Dividend Yield: N/A%
ROE: 101.12%
Latest News
-
TG Therapeutics Secures an Additional $500 Million in Non-Dilutive Capital from Blue Owl and Expands Share Repurchase Program to $300 Million
Thu, Mar 19, 2026 11:30 AM
-
TG Therapeutics Board Authorizes Increase To Share Repurchase Program From $100M To $300M
Thu, Mar 19, 2026 7:38 AM
-
TG Therapeutics Enters Into 5-Yr, $750M Senior Secured Credit Facility With Funds Managed By Blue Owl Capital; Co. To Repay Outstanding $250M Senior Secured Credit Facility, Resulting In Net Raise Of $500M In Non-Dilutive Capital
Thu, Mar 19, 2026 7:37 AM
Key Financials
Financial data not available
